第三代芳香化酶抑制剂在绝经后乳腺癌新辅助内分泌治疗中的应用(4)
[15] Harvell DM, Spoelstra NS, Singh M,et al.Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of esponse or intrinsic resistance. Breast Cancer Res Treat,2008,112(3):475-488.
[16] Ellis MJ, Coop A, Singh B,et al. Letrozole inhibits tumor roliferation more effectively than tamoxifen independent of HER1/2 expression status. Cancer Res,2003,63(19):523-6531.
[17] Dowsett M, Ebbs SR, Dixon JM,et al. Biomarker changes during neoadjuvant anastrozole, tamoxifen,or the combination independence of hormonal status and HER-2 in breast cancer-a study from the IMPACT trialists.J Clin Oncol,2005,23(11):2477-2492.
[18] Ellis MJ, Coop A, Singh B,et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1-and/orErbB-2-positive, estrogen receptor-positive primary breast cancer:evidence from a phase Ⅲ randomized trial.J Clin，Oncol，2001,19(18): 3808-3816.
[19] Barnadas A, Gil M, Sánchez-Rovira P， et al. Neoadjuvant endocrine therapy for breast cancer: past, present and future. Anti -cancer,2008,19(4):339-347.
(收稿日期：2011-04-13)
(本文编辑：王春芸), 百拇医药(王万忠 种瑞峰 郑敏 齐恒)
[16] Ellis MJ, Coop A, Singh B,et al. Letrozole inhibits tumor roliferation more effectively than tamoxifen independent of HER1/2 expression status. Cancer Res,2003,63(19):523-6531.
[17] Dowsett M, Ebbs SR, Dixon JM,et al. Biomarker changes during neoadjuvant anastrozole, tamoxifen,or the combination independence of hormonal status and HER-2 in breast cancer-a study from the IMPACT trialists.J Clin Oncol,2005,23(11):2477-2492.
[18] Ellis MJ, Coop A, Singh B,et al. Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1-and/orErbB-2-positive, estrogen receptor-positive primary breast cancer:evidence from a phase Ⅲ randomized trial.J Clin，Oncol，2001,19(18): 3808-3816.
[19] Barnadas A, Gil M, Sánchez-Rovira P， et al. Neoadjuvant endocrine therapy for breast cancer: past, present and future. Anti -cancer,2008,19(4):339-347.
(收稿日期：2011-04-13)
(本文编辑：王春芸), 百拇医药(王万忠 种瑞峰 郑敏 齐恒)